These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 27273824)

  • 21. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.
    Kim C; Holm M; Frost I; Hasso-Agopsowicz M; Abbas K
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37414432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization as a tool to combat antimicrobial resistance.
    Spika J; Rud EW
    Can Commun Dis Rep; 2015 Nov; 41(Suppl 5):7-10. PubMed ID: 29769969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of cerebrospinal isolates from patients with meningitis.
    Liskova A; Benca J; Kalavsky E; Kovac M; Rudinsky B; Ondrusova A; Kiwou M
    Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():5-6. PubMed ID: 18030262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.
    Torumkuney D; Zemlickova H; Maruscak M; Morrissey I
    J Antimicrob Chemother; 2018 Apr; 73(suppl_5):v22-v27. PubMed ID: 29659883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of vaccines in combatting antimicrobial resistance.
    Micoli F; Bagnoli F; Rappuoli R; Serruto D
    Nat Rev Microbiol; 2021 May; 19(5):287-302. PubMed ID: 33542518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region.
    Tzanakaki G; Mastrantonio P
    Int J Antimicrob Agents; 2007 Jun; 29(6):621-9. PubMed ID: 17368858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
    Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of antibiotic resistance in hospitals, 1935-1975.
    Finland M
    Rev Infect Dis; 1979; 1(1):4-22. PubMed ID: 45521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological profile of invasive bacterial diseases in children in Casablanca, Morocco: antimicrobial susceptibilities and serotype distribution.
    El Mdaghri N; Jilali N; Belabbes H; Jouhadi Z; Lahssoune M; Zaid S
    East Mediterr Health J; 2012 Nov; 18(11):1097-101. PubMed ID: 23301370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiologic effect of bovine cerebrospinal fluid and azithromycin against Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae.
    Destache CJ; Pakiz CB; Kersting K
    Pharmacotherapy; 1997; 17(5):985-9. PubMed ID: 9324186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nasopharyngeal carriage, antibiotic susceptibility and serotyping of Streptococcus pneumoniae and Haemophilus influenzae in children attending day care centers].
    Chavanet P; Atale A; Mahy S; Neuwirth C; Varon E; Dabernat H; Portier H
    Med Mal Infect; 2011 Jun; 41(6):307-17. PubMed ID: 21429682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
    Trucchi C; Zoppi G
    J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis.
    Lieberman JM; Greenberg DP; Ward JI
    Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of human vaccines on bacterial antimicrobial resistance. A review.
    Jansen KU; Gruber WC; Simon R; Wassil J; Anderson AS
    Environ Chem Lett; 2021; 19(6):4031-4062. PubMed ID: 34602924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New spectra of resistance of the main bacteria of the respiratory tract].
    Mariani-Kurkdjian P; Bingen E
    Arch Pediatr; 1998; 5 Suppl 1():14s-17s. PubMed ID: 10223155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of drug resistance. Impact on bacterial meningitis.
    Klugman KP; Madhi SA
    Infect Dis Clin North Am; 1999 Sep; 13(3):637-46, vii. PubMed ID: 10470559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines and antibiotic resistance.
    Mishra RP; Oviedo-Orta E; Prachi P; Rappuoli R; Bagnoli F
    Curr Opin Microbiol; 2012 Oct; 15(5):596-602. PubMed ID: 22981392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.